✦ LIBER ✦

Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma

✍ Scribed by Paul Haluska; Frank Worden; David Olmos; Donghua Yin; David Schteingart; Gretchen N. Batzel; M. Luisa Paccagnella; Johann S. de Bono; Antonio Gualberto; Gary D. Hammer

Book ID: 105993229
Publisher: Springer
Year: 2009
Tongue: English
Weight: 425 KB
Volume: 65
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-009-1083-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, Tolerability, Pharmacokinetics,

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-TWEAK Monoclonal Antibody in Patients With Rheumatoid Arthritis

✍ Wisniacki, Nicolas; Amaravadi, Lakshmi; Galluppi, Gerald R.; Zheng, Timothy S.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 347 KB

Safety, pharmacokinetics, and preliminar

Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study

✍ David Olmos; Sophie Postel-Vinay; L Rhoda Molife; Scott H Okuno; Scott M Schuetz 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 398 KB

1227 A phase 1, dose-escalation study of

1227 A phase 1, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in patients with relapsed or refractory solid tumours

✍ M. von Mehren; C. Britten; P. Piesolor; K. Balogh; A. Bartok; S. Harris; X. Li; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Phase 1b study of safety, tolerability a

Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies

✍ Mahadevan, Daruka; Sutton, Gregory Ryan; Arteta-Bulos, Rafael; Bowden, Chris J.; 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 747 KB

388 POSTER Safety, pharmacokinetics and

388 POSTER Safety, pharmacokinetics and preliminary activity of the anti-IGF-IR antibody CP-751,871 in patients with sarcoma

✍ S. Postel-Vinay; S. Okuno; S. Schuetze; M.L. Paccagnella; D. Yin; A. Gualberto; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Safety, pharmacokinetics and pharmacodyn

Safety, pharmacokinetics and pharmacodynamics of the anti-A33 fully-human monoclonal antibody, KRN330, in patients with advanced colorectal cancer

✍ Infante, Jeffrey R.; Bendell, Johanna C.; Goff, Laura Williams; Jones, Suzanne F 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 511 KB